Synergistic interaction between MEK inhibitor and gefitinib in EGFRTKIresistant human lung cancer cells

Author：

E-ISSN： 1792-1082|10|4|2652-2656

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.4, 2015-01, pp. : 2652-2656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synergistic interaction between sorafenib and gemcitabine in EGFRTKIsensitive and EGFRTKIresistant human lung cancer cell lines

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 440-446

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib combined with gemcitabine in EGFRTKIresistant human lung cancer cells

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 68-72

Spandidos Publications

Access to resources Recommend Favorite

Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling

By Wang Zi-li

Carcinogenesis, Vol. 34, Iss. 3, 2013-03 ,pp. : 638-646

Oxford University Press

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

Synergistic Interaction Between Vinorelbine and Gamma-Linolenic Acid in Breast Cancer Cells

By Menéendez Javier Ropero Santiago Barbacid Maria Montero Sagrario Solanas Montserrat Escrich Eduard Cortés-Funes Hernán Colomer Ramon

Breast Cancer Research and Treatment, Vol. 72, Iss. 3, 2002-04 ,pp. : 203-219

Springer Publishing Company

Access to resources Recommend Favorite